We are live on ! Find out more
NKGN

NKGen Biotech, Inc. Common Stock
NKGN

Delisted

NKGN was delisted on the 4th of March, 2025.

Back to rankings

43 hedge funds and large institutions have $117M invested in NKGen Biotech, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 3

40% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 5

7% more capital invested

Capital invested by funds: $109M → $117M (+$7.84M)

5% more funds holding

Funds holding: 41 → 43 (+2)

Holders
43
Holders Change
+2
Holders Change %
+4.88%
% of All Funds
0.68%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
6
Reduced
3
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
+$4.84M
2
PSAMP
P. Schoenfeld Asset Management (PSAM)
New York
+$3.88M
3
FBCM
Fort Baker Capital Management
California
+$2.68M
4
AIMCA
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
+$1.94M
5
CL
CSS LLC
Illinois
+$1.84M

Top Sellers

Rank Fund Capital Flow
1
UOC
UBS O'Connor
Illinois
-$3.41M
2
HIH
HRS Investment Holdings
New York
-$2.47M
3
NRCM
Northern Right Capital Management
Connecticut
-$1.45M
4
VCIM
Velan Capital Investment Management
Georgia
-$836K
5
EAM
Exos Asset Management
New York
-$678K
Name Holding Trade Value Shares
Change 		Change in
Stake
Adage Capital Partners
1
Adage Capital Partners
Massachusetts
$13.1M – – –
HCM
2
Highbridge Capital Management
New York
$10.9M – – –
RCM
3
Radcliffe Capital Management
Pennsylvania
$5.85M +$27.1K +2,800 +0.5%
PC
4
Periscope Capital
Ontario, Canada
$5.82M – – –
KC
5
Kepos Capital
New York
$5.09M – – –
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
6
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
$4.85M +$4.84M +500,000 New
6CM
7
683 Capital Management
New York
$4.85M – – –
FTCM
8
Fir Tree Capital Management
New York
$4.85M – – –
SCC
9
Spring Creek Capital
Kansas
$4.47M – – –
SCM
10
Saba Capital Management
New York
$4.03M – – –
Balyasny Asset Management
11
Balyasny Asset Management
Illinois
$3.88M – – –
PSAMP
12
P. Schoenfeld Asset Management (PSAM)
New York
$3.88M +$3.88M +400,000 New
Goldman Sachs
13
Goldman Sachs
New York
$3.54M – – –
TCA
14
Taconic Capital Advisors
New York
$3.4M – – –
Bank of America
15
Bank of America
North Carolina
$3.39M – – –
FBCM
16
Fort Baker Capital Management
California
$2.93M +$2.68M +276,990 +1,121%
PAMP
17
Polar Asset Management Partners
Ontario, Canada
$2.91M – – –
CL
18
CSS LLC
Illinois
$2.82M +$1.84M +189,424 +187%
CFIA
19
Cantor Fitzgerald Investment Advisors
New York
$2.47M – – –
SCM
20
Shaolin Capital Management
Florida
$2.46M – – –
D.E. Shaw & Co
21
D.E. Shaw & Co
New York
$2.45M – – –
Millennium Management
22
Millennium Management
New York
$2.37M – – –
AIMCA
23
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$1.94M +$1.94M +200,000 New
RCM
24
Rivernorth Capital Management
Florida
$1.91M -$32.8K -3,385 -2%
CSS
25
Cubist Systematic Strategies
Connecticut
$1.63M -$63.3K -6,530 -4%
1
2

NKGN Hedge Fund Activity: Q1 2022 in Review

43 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in NKGen Biotech, Inc. Common Stock (NKGN) for Q1 2022, worth a combined $117M — up 7.2% from $109M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new NKGN positions and 5 closed out — a net gain of 2 holders — while 6 added to existing stakes and 3 trimmed.

The largest buyer was Healthcare of Ontario Pension Plan (HOOPP) Trust Fund, opening a new position worth an estimated $4.84M. The largest seller was UBS O'Connor, exiting entirely with an estimated $3.41M sold.

  • 43 institutional investors held NKGen Biotech, Inc. Common Stock (NKGN) as of Q1 2022, up from 41 in Q4 2021.
  • Funds reported $117M of NKGen Biotech, Inc. Common Stock stock for Q1 2022, up 7.2% quarter-over-quarter.
  • 7 funds opened new NKGen Biotech, Inc. Common Stock positions in Q1 2022 and 5 closed out, a net change of +2 holders.
  • The largest NKGen Biotech, Inc. Common Stock buyer in Q1 2022 was Healthcare of Ontario Pension Plan (HOOPP) Trust Fund, an estimated $4.84M added.
  • The largest NKGen Biotech, Inc. Common Stock seller in Q1 2022 was UBS O'Connor, an estimated $3.41M sold.

Based on aggregated 13F filings for Q1 2022.